本页面由Tiger Trade Technology Pte. Ltd.提供服务

Humacyte, Inc.

1.23
-0.0700-5.38%
盘后1.230.00000.00%19:57 EST
成交量:395.86万
成交额:500.26万
市值:2.30亿
市盈率:-4.76
高:1.31
开:1.29
低:1.23
收:1.30
52周最高:6.77
52周最低:1.09
股本:1.87亿
流通股本:1.54亿
量比:1.26
换手率:2.57%
股息:- -
股息率:- -
每股收益(TTM):-0.2583
每股收益(LYR):-1.2551
净资产收益率:-249.75%
总资产收益率:-63.44%
市净率:-48.48
市盈率(LYR):-0.98

数据加载中...

2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/20

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/28

重要事件披露

Form 8-K - Current report
2024/10/07

重要事件披露

Form 8-K - Current report
2024/09/25

重要事件披露

Form 8-K - Current report
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities